Kevin K. Buckbee - 26 Feb 2025 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
SVP, CONTROLLER
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Kevin K. Buckbee
Issuer symbol
ABBV
Transactions as of
26 Feb 2025
Net transactions value
-$3,853,372
Form type
4
Filing time
28 Feb 2025, 17:00:09 UTC
Previous filing
18 Feb 2025
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Sale $545,926 -2,684 -18% $203.40 12,646 26 Feb 2025 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $910,503 +9,738 +77% $93.50 22,384 26 Feb 2025 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $690,810 +6,522 +29% $105.92 28,906 26 Feb 2025 Direct
transaction ABBV Common Stock, $0.01 par value Sale $3,307,447 -16,260 -59% $203.41 11,496 26 Feb 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to buy) Options Exercise $910,503 -9,738 -80% $93.50 2,373 26 Feb 2025 Common Stock 9,738 $93.50 Direct F3
transaction ABBV Option (Right to buy) Options Exercise $690,810 -6,522 -70% $105.92 2,794 26 Feb 2025 Common Stock 6,522 $105.92 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.39 to $203.48, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The reporting person transferred 1,150 shares of common stock to his former spouse pursuant to a domestic relations order since his last ownership report and has ceased to be the beneficial owner of such shares.
F3 Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.